Compare · AIRS vs HIMS
AIRS vs HIMS
Side-by-side comparison of AirSculpt Technologies Inc. (AIRS) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIRS and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $4.62B, about 74.4x AIRS ($62.1M).
- HIMS has been more active in the news (15 items in the past 4 weeks vs 10 for AIRS).
- HIMS has more recent analyst coverage (25 ratings vs 9 for AIRS).
- Company
- AirSculpt Technologies Inc.
- Hims & Hers Health Inc.
- Price
- -
- -
- Market cap
- $62.1M
- $4.62B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2019
- News (4w)
- 10
- 15
- Recent ratings
- 9
- 25
AirSculpt Technologies Inc.
AirSculpt Technologies, Inc. focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of October 5, 2021, it operated 16 centers across 13 states. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest AIRS
- Chief Executive Officer Jashnani Yogesh bought $24,047 worth of shares (31,000 units at $0.78), increasing direct ownership by 4% to 726,475 units (SEC Form 4)
- AirSculpt Technologies Announces First-Ever Nationwide Open House Event, "The Gift of Body Confidence"
- AirSculpt Technologies Announces Participation in the A.G.P. Virtual Consumer Showcase
- SEC Form 10-Q filed by AirSculpt Technologies Inc.
- AirSculpt Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- AirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- AirSculpt Technologies Reports Third Quarter Fiscal 2026 Results
- AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Third Quarter Fiscal 2026 Results
- Lake Street initiated coverage on AirSculpt Technologies with a new price target
- Amendment: SEC Form SCHEDULE 13G/A filed by AirSculpt Technologies Inc.
Latest HIMS
- Director Payne Christopher D was granted 810 restricted stock units (SEC Form 4)
- Chief Accounting Officer Franklin Jonathan M was granted 102,774 restricted stock units (SEC Form 4)
- Director Wells David B was granted 1,051 restricted stock units (SEC Form 4)
- Director Huberman Andrew D was granted 19,301 restricted stock units (SEC Form 4)
- SEC Form 3 filed by new insider Huberman Andrew D
- Nasdaq Jumps Over 4% This Week as Chip Names Drive a Sharp Midweek Rally
- SEC Form 10-Q filed by Hims & Hers Health Inc.
- Hims & Hers Health Inc. filed SEC Form 8-K: Leadership Update
- Hims & Hers Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Hims & Hers Health, Inc. Reports Third Quarter 2026 Financial Results